An Open Trial of a Smartphone-assisted, Adjunctive Intervention to Improve Treatment Adherence in Bipolar Disorder

被引:17
|
作者
Wenze, Susan J. [1 ,2 ]
Armey, Michael F. [2 ,3 ]
Weinstock, Lauren M. [2 ,3 ]
Gaudiano, Brandon A. [2 ,3 ]
Miller, Ivan W. [2 ,3 ]
机构
[1] Lafayette Coll, Dept Psychol, Easton, PA 18042 USA
[2] Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Providence, RI 02912 USA
[3] Butler Hosp, Psychosocial Res Program, Providence, RI 02906 USA
关键词
adherence; bipolar disorder; ecological momentary intervention; mobile health; smartphone; RANDOMIZED CONTROLLED-TRIAL; MEDICATION ADHERENCE; LITHIUM MAINTENANCE; MOBILE INTERVENTION; ADDICTIVE-DISORDERS; MOOD STABILIZERS; SUBSTANCE USE; PRIMARY-CARE; HEALTH; HOSPITALIZATION;
D O I
10.1097/PRA.0000000000000196
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
We evaluated the feasibility and acceptability of a novel, 12-week, adjunctive, smartphone-assisted intervention to improve treatment adherence in bipolar disorder. Eight participants completed 4 in-person individual therapy sessions over the course of a month, followed by 60 days of twice-daily ecological momentary intervention (EMI) sessions, with a fifth in-person session after 30 days and a sixth in-person session after 60 days. Perceived credibility of the intervention and expectancy for change were adequate at baseline, and satisfaction on completion of the intervention was very high. Participants demonstrated good adherence to the intervention overall, including excellent adherence to the in-person component and fair adherence to the smartphone-facilitated component. Qualitative feedback revealed very high satisfaction with the in-person sessions and suggested a broad range of ways in which the EMI sessions were helpful. Participants also provided suggestions for improving the intervention, which primarily related to the structure and administration of the EMI (smartphone-administered) sessions. Although this study was not designed to evaluate treatment efficacy, most key outcome variables changed in the expected directions from pretreatment to posttreatment, and several variables changed significantly over the course of the in-person sessions or during the EMI phase. These findings add to the small but growing body of literature suggesting that EMIs are feasible and acceptable for use in populations with bipolar disorder.
引用
收藏
页码:492 / 504
页数:13
相关论文
共 50 条
  • [21] Smartphone-assisted technique in total hip arthroplasty can improve the precision of acetabular cup placement: a randomised controlled trial
    Pongkunakorn, Anuwat
    Diewwattanawiwat, Kittipong
    Chatmaitri, Swist
    HIP INTERNATIONAL, 2021, 31 (01) : 50 - 57
  • [22] A double-blind, randomized, placebo-controlled plus open trial of adjunctive suvorexant for treatment-resistant insomnia in patients with bipolar disorder
    Cafaro, Rita
    Macellaro, Monica
    Suppes, Trisha
    Dell'Osso, Bernardo
    Ketter, Terence
    Ostacher, Michael
    Miller, Shefali
    Chang, Lauren
    Lyu, Jihun
    Wang, Po W.
    CNS SPECTRUMS, 2024, 29 (05) : 376 - 384
  • [23] The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial
    Berk, Michael
    Dean, Olivia
    Cotton, Sue M.
    Gama, Clarissa S.
    Kapczinski, Flavio
    Fernandes, Brisa S.
    Kohlmann, Kristy
    Jeavons, Susan
    Hewitt, Karen
    Allwang, Christine
    Cobb, Heidi
    Bush, Ashley I.
    Schapkaitz, Ian
    Dodd, Seetal
    Malhi, Gin S.
    JOURNAL OF AFFECTIVE DISORDERS, 2011, 135 (1-3) : 389 - 394
  • [24] A Pilot Randomized Controlled Trial of Smartphone-Assisted Mindfulness-Based Intervention With Contingency Management for Smokers With Mood Disorders
    Minami, Haruka
    Nahvi, Shadi
    Arnsten, Julia H.
    Brinkman, Hannah R.
    Rivera-Mindt, Monica
    Wetter, David W.
    Bloom, Erika Litvin
    Price, Lawrence H.
    Richman, Elise K.
    Betzler, Thomas F.
    Stockmal, Corinne
    Donnelly, Remington
    McClain, Lauren M.
    Kennedy, Katherine A.
    Vieira, Carlos
    Fine, Micki
    McCarthy, Danielle E.
    Thomas, J. Graham
    Hecht, Jacki
    Brown, Richard A.
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2022, 30 (05) : 653 - 665
  • [25] Is adjunctive open-label zonisarnide effective for bipolar disorder?
    Ghaemi, S. Nassir
    Shirzadi, Arshia A.
    Klugman, Jeffry
    Berv, Douglas A.
    Pardo, Tamara B.
    Filkowski, Megan M.
    JOURNAL OF AFFECTIVE DISORDERS, 2008, 105 (1-3) : 311 - 314
  • [26] A brief motivational intervention to improve medication adherence among youth with bipolar disorder: a pilot study
    Goldstein, T. R.
    Fersch-Podrat, R.
    Hotkowski, N.
    Price, R.
    Garcia, M.
    Loren, S.
    Axelson, D. A.
    Birmaher, B.
    Douaihy, A.
    BIPOLAR DISORDERS, 2013, 15 : 99 - 99
  • [27] Adjunctive tianeptine treatment for bipolar disorder: A 24-week randomized, placebo-controlled, maintenance trial
    Kauer-Sant'Anna, Marcia
    Frey, Benicio N.
    Fijtman, Adam
    Loredo-Souza, Ana C.
    Dargel, Aroldo A.
    Pfaffenseller, Bianca
    Wollenhaupt-Aguiar, Bianca
    Gazalle, Fernando K.
    Colpo, Gabriela D.
    Passos, Ives C.
    Bucker, Joana
    Walz, Julio C.
    Jansen, Karen
    Mendes Cereser, Keila M.
    Burke Bridi, Kelen P.
    Soria, Lisiane dos Santos
    Kunz, Mauricio
    Pinho, Michele
    Kapczinski, Natalia S.
    Goi, Pedro D.
    Magalhaes, Pedro V. S.
    Reckziegel, Ramiro
    Burque, Renan K.
    Cardoso, Taiane de Azevedo
    Kapczinski, Flavio
    JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (04) : 502 - 510
  • [28] Using mHealth to improve adherence and reduce blood pressure in individuals with hypertension and bipolar disorder (iTAB-CV): study protocol for a 2-stage randomized clinical trial
    Levin, Jennifer B.
    Moore, David J.
    Depp, Colin
    Montoya, Jessica L.
    Briggs, Farren
    Rahman, Mahboob
    Stange, Kurt C.
    Einstadter, Douglas
    Weise, Celeste
    Conroy, Carla
    Yala, Joy
    Radatz, Ethan
    Sajatovic, Martha
    TRIALS, 2022, 23 (01)
  • [29] Treatment Adherence in Patients with Bipolar Disorder and Beliefs Related to Non-Adherence
    Uygun, Ersin
    Kucukgoncu, Suat
    PSYCHIATRY AND BEHAVIORAL SCIENCES, 2020, 10 (04): : 192 - 198
  • [30] Acute treatment of bipolar disorder with adjunctive risperidone in outpatients
    Ghaemi, SN
    Sachs, GS
    Baldassano, CF
    Truman, CJ
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1997, 42 (02): : 196 - 199